Bluebird Bio
Latest round
- Series D
Last raised
- Jul 2012
Total raised
- $125M
Investors
- 9
About Bluebird Bio
Founded in 1993 and based in Massachusetts, US, Bluebird Bio, Inc. operates as a biotechnology company that develops and provides gene therapy, cancer immunotherapy, and gene editing platforms to cure patients with genetic and rare diseases.
Who invested in Bluebird Bio
9 investors across 3 rounds
See all investors in Bluebird Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Bluebird Bio
Who invested in Bluebird Bio?
Bluebird Bio has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bluebird Bio raised?
Bluebird Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Bluebird Bio last raise money?
Bluebird Bio's most recent round on record is a Series D, in Jul 2012.
What does Bluebird Bio do?
Founded in 1993 and based in Massachusetts, US, Bluebird Bio, Inc.
Where is Bluebird Bio headquartered?
Bluebird Bio is headquartered in Somerville, US.
Which VCs invest in companies like Bluebird Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Bluebird Bio's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Bluebird Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.